Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
That's what I'm saying
[2] Implications of a Schedule II status Under the CSA, substances are listed within five categories, ranging from Schedule I substances, which are deemed the most dangerous, to Schedule V
Zepbound is approved only for adults, but as of this writing, it is being studied for use in adolescents
The key takeaway is this
Most common side effects (12mg dose, across TRIUMPH-4 and TRIUMPH-1): Nausea: 43% TRIUMPH-4 / ~38% TRIUMPH-1 (mostly during dose escalation) Diarrhea: 33% / ~28% (peaks weeks 48, improves by week 16) Dysesthesia: 20.9% (tingling sensations onset variable, long-term persistence unknown) Vomiting: 21% / ~25% (decreases after month 3) Constipation: 25% Discontinuation rates: 18.2% in TRIUMPH-4 (osteoarthritis population), 11.3% in TRIUMPH-1 (general obesity population)
US$ 22.55
US$ 22.96
US$ 29.28
US$ 26.61
US$ 20.17
US$ 26.44
US$ 25.21
